These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 8960272)

  • 1. Esters of cephalosporins. Part I. Permeability of cefuroxime liberated from its 1-acetoxyethyl ester through biological membranes; influence of the form and size of the ester particles.
    Sasinowska-Motyl M; Wiśniewska I; Gumułka W; Oszczapowicz I; Szelachowska M; Interewicz B
    Acta Pol Pharm; 1995; 52(5):391-5. PubMed ID: 8960272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Esters of cephalosporins. Part II. Differences in the properties of various forms of the 1-acetoxyethyl ester of cefuroxime.
    Oszczapowicz I; Małafiej E; Szelachowska M; Horoszewicz-Małafiej A; Kuklewicz C; Sierańska E; Denys A; Niedworok J
    Acta Pol Pharm; 1995; 52(5):397-401. PubMed ID: 8960273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Esters of cephalosporins. Part VI. Properties of the beta-form of 1-acetoxyethyl ester of cefuroxime.
    Oszczapowicz I; Tejchman B; Zimniak A; Oszczapowicz J
    Acta Pol Pharm; 1998; 55(3):197-204. PubMed ID: 9735700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Esters of cephalosporins. Part IV. Hydrolysis of 1-acetoxyethyl ester of cefuroxime in vitro and in vivo.
    Tejchman B; Jaromińska M; Horodecka M; Oszczapowicz I
    Acta Pol Pharm; 1995; 52(6):477-82. PubMed ID: 8960266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Esters of cephalosporins. Part III. Separation and properties of the R and S isomers of the 1-acetoxyethyl ester of cefuroxime.
    Oszczapowicz I; Małafiej E; Horoszewicz-Małafiej A; Szelachowska M; Kuklewicz C; Sierańska E
    Acta Pol Pharm; 1995; 52(6):471-6. PubMed ID: 8960265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a microencapsulated form of cefuroxime axetil using pH-sensitive acrylic polymers.
    Lorenzo-Lamosa ML; Cuña M; Vila-Jato JL; Torres D; Alonso MJ
    J Microencapsul; 1997; 14(5):607-16. PubMed ID: 9292436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of dose and food on the bioavailability of cefuroxime axetil.
    Finn A; Straughn A; Meyer M; Chubb J
    Biopharm Drug Dispos; 1987; 8(6):519-26. PubMed ID: 3427209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stereoselective absorption and hydrolysis of cefuroxime axetil diastereomers using the Caco-2 cell monolayer model.
    Barrett MA; Lawrence MJ; Hutt AJ; Lansley AB
    Eur J Drug Metab Pharmacokinet; 1997; 22(4):409-13. PubMed ID: 9512942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intestinal transport of cefuroxime axetil in rats: absorption and hydrolysis processes.
    Ruiz-Balaguer N; Nacher A; Casabo VG; Merino Sanjuan M
    Int J Pharm; 2002 Mar; 234(1-2):101-11. PubMed ID: 11839441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and absolute bioavailability of oral cefuroxime axetil in the rat.
    Ruiz-Carretero P; Nacher A; Merino-Sanjuan M; Casabo VG
    Int J Pharm; 2000 Jul; 202(1-2):89-96. PubMed ID: 10915930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An investigation into the release of cefuroxime axetil from taste-masked stearic acid microspheres. Part 1: the influence of the dissolution medium on the drug release profile and the physical integrity of the microspheres.
    Robson HJ; Craig DQ; Deutsch D
    Int J Pharm; 1999 Nov; 190(2):183-92. PubMed ID: 10547458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacology of Cefuroxime as the 1-acetoxyethyl ester in volunteers.
    Harding SM; Williams PE; Ayrton J
    Antimicrob Agents Chemother; 1984 Jan; 25(1):78-82. PubMed ID: 6703686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An investigation into the release of cefuroxime axetil from taste-masked stearic acid microspheres. III. The use of DSC and HSDSC as means of characterising the interaction of the microspheres with buffered media.
    Robson H; Craig DQ; Deutsch D
    Int J Pharm; 2000 May; 201(2):211-9. PubMed ID: 10878327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical studies on cefuroxime axetil in acute mastitis].
    Nakamura T; Hashimoto I; Sawada Y; Mikami J
    Jpn J Antibiot; 1987 Feb; 40(2):340-8. PubMed ID: 3599383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical efficacy of Cefuroxime axetil in S. typhi.
    Mathur YC; Mathur NC; Lal HM
    Indian Pediatr; 1996 Dec; 33(12):1033-7. PubMed ID: 9141805
    [No Abstract]   [Full Text] [Related]  

  • 16. [Oral cephalosporins. Role of cefuroxime-axetil].
    Bergogne-Berezin E
    Therapie; 1988; 43 Suppl 4():343-9. PubMed ID: 3065977
    [No Abstract]   [Full Text] [Related]  

  • 17. Cefuroxime concentrations in serum, joint fluid and bone in elderly patients undergoing arthroplasty after administration of cefuroxime axetil.
    Renneberg J; Christensen OM; Thomsen NO; Tørholm C
    J Antimicrob Chemother; 1993 Nov; 32(5):751-5. PubMed ID: 8125839
    [No Abstract]   [Full Text] [Related]  

  • 18. [Stepwise therapy of community-acquired pneumonia. Results of cefuroxime and cefuroxime axetil study].
    Iakovlev SV; Suvorova MP; Dvoretskiĭ LI; Vlasenko NA; Shakhova TV
    Antibiot Khimioter; 1998; 43(6):7-11. PubMed ID: 9644527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cefuroxime. Pharmacokinetic aspects in man after intravenous administration under different conditions].
    Orsolini P; Xerri L; Vallaperta P; Pugina M
    G Ital Chemioter; 1979; 26(1-2):145-8. PubMed ID: 554803
    [No Abstract]   [Full Text] [Related]  

  • 20. In vitro and in vivo evaluations of the metabolism, pharmacokinetics, and bioavailability of ester prodrugs of L-767,679, a potent fibrinogen receptor antagonist: an approach for the selection of a prodrug candidate.
    Prueksaritanont T; Gorham LM; Breslin MJ; Hutchinson JH; Hartman GD; Vyas KP; Baillie TA
    Drug Metab Dispos; 1997 Aug; 25(8):978-84. PubMed ID: 9280406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.